Clinical Trial

Pentoxifylline for Prevention of Contrast Induced Nephropathy in Chronic Kidney Diseased Patients in Intensive Care Unit

Name: Pentoxifylline for Prevention of Contrast Induced Nephropathy in Chronic Kidney Diseased Patients in Intensive Care Unit — clinical trial record (NCT07561801)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

The aim of this study is to evaluate the effect of pentoxifylline for control of contrast induced nephropathy in chronic kidney diseased patients in intensive care unit.

Trial Details

NCT Number	NCT07561801
Lead Sponsor	Tanta University
Conditions	Pentoxifylline, Contrast Induced Nephropathy, Chronic Kidney Disease, Intensive Care Unit
Enrollment	70 participants
Start Date	2024-07-01
Primary Completion	2025-06-01 (estimated)
Study Completion	2025-06-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-01